Kairos Pharma Ltd. (KAPA)
AMEX: KAPA
· Real-Time Price · USD
1.19
-0.05 (-4.03%)
At close: Aug 15, 2025, 3:59 PM
1.25
5.21%
Pre-market: Aug 18, 2025, 05:25 AM EDT
Kairos Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -1.42M | -1.26M | -980K | -1.05M | -253K | -323K | -1.12M | -312K | -236K | -146K | -196K | -234K | -385K | -235K |
Depreciation & Amortization | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 50K | 50K | 50K | 130K | 290K | 98K |
Stock-Based Compensation | n/a | 76K | 218K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -669K | 619K | 1.37M | -1.7M | 26K | 299K | 205K | 353K | -9K | -17K | 5K | 5K | 4K | -14K |
Other Non-Cash Items | 1.38M | n/a | -2.46M | 686K | 19K | 20K | 939K | 10K | 127K | 105K | 72K | 47K | 7K | 3K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -798K | 432K | 1.37M | -1.7M | 26K | 299K | 205K | 353K | -9K | -17K | 5K | 5K | 4K | -14K |
Operating Cash Flow | -805K | -714K | -1.8M | -2.02M | -168K | 36K | 66K | 91K | -68K | -8K | -69K | -52K | -84K | -148K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | -40K | 40K | 102K | n/a | n/a | n/a | n/a | n/a | n/a | 225K | 450K | 250K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 223K | n/a | 288K | -390K | n/a | n/a | n/a | n/a | -57K | -72K | -17K | -34K | -147K | -10K |
Financial Cash Flow | 223K | 3.06M | -142K | 5.22M | 149K | -89K | -72K | -224K | -57K | -72K | -17K | 191K | 303K | 240K |
Net Cash Flow | -582K | 2.34M | -1.95M | 3.2M | -19K | -53K | -6K | -133K | -125K | -80K | -86K | 139K | 219K | 165K |
Free Cash Flow | -805K | -714K | -1.8M | -2.02M | -168K | 36K | 66K | 91K | -68K | -8K | -69K | -52K | -84K | -148K |